P43 THE ROLE OF B7.1 AND suPAR IN PODOCYTE INJURY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Main Authors: | F. Vincenti, C. Craik, E. Harel, D. Dobi, Z. Laszik |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-11-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024916301280 |
Similar Items
-
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab
by: Nada Alachkar, et al.
Published: (2018-12-01) -
Podocyte number and glomerulosclerosis indices are associated with the response to therapy for primary focal segmental glomerulosclerosis
by: Natasha de Zoysa, et al.
Published: (2024-03-01) -
SuPAR mediates viral response proteinuria by rapidly changing podocyte function
by: Changli Wei, et al.
Published: (2023-07-01) -
Proteomics of Plasma and Plasma-Treated Podocytes: Application to Focal and Segmental Glomerulosclerosis
by: Cerina Chhuon, et al.
Published: (2023-07-01) -
Therapeutic potential targeting podocyte mitochondrial dysfunction in focal segmental glomerulosclerosis
by: Yuting Li, et al.
Published: (2023-03-01)